SHF Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SHF Holdings, Inc. (SHFS) on May 6, 2026. The filing addresses a voluntary reduction in the conversion price of Series B Convertible Preferred Stock and the exercise price of Series B Warrants, originally issued under a Securities Purchase Agreement dated September 30, 2025.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial data disclosed relates to capital structure adjustments:
- Reduced Conversion Price: $0.65 per share for Series B Preferred Stock.
- Reduced Exercise Price: $0.65 per share for Series B Warrants.
- Conversion Reduction Period: May 6, 2026, through July 31, 2026.
- Exercise Reduction Period: Effective upon SEC declaration of the Reduced Price Registration Statement (Form S-1) until July 31, 2026.
Material Changes
The material change reported is the voluntary reduction of the conversion and exercise prices to $0.65, approved by the Board of Directors and the Required Holder. This action is intended to facilitate the conversion of preferred stock and exercise of warrants into common stock. The company intends to file a Form S-1 to register the additional shares issuable upon exercise at the reduced price.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the company's ability to maintain Nasdaq listing compliance and the effectiveness of the registration statement. Key risks and contingencies identified include:
- Uncertainty regarding the ability to regain or maintain Nasdaq listing standards.
- Market conditions impacting the ability to access or utilize an Equity Line of Credit (ELOC).
- Volatility in capital markets affecting security prices.
- Regulatory changes in the cannabis industry impacting Safe Harbor's services.
- Potential legal proceedings.
Investor Verification Checklist
- Verify the effectiveness date of the Form S-1 registration statement to confirm the start of the Exercise Reduction Period.
- Confirm the total number of Series B Preferred Stock and Warrants outstanding to assess potential dilution at the $0.65 price point.
- Monitor Nasdaq compliance status and any subsequent communications regarding listing standards.
- Review the terms of the Equity Line of Credit (ELOC) and conditions required for its utilization.